Global Robot Assisted Pci Market
Market Size in USD Billion
CAGR :
% 
USD
18.33 Billion
USD
224.84 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 18.33 Billion |
 Market Size (Forecast Year) |
USD 224.84 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Robot Assisted Percutaneous Coronary Intervention (PCI) Market Segmentation, By Product Type (Robot-assisted Procedures and Fully Automated Procedures), Component (Robotic Systems, Control Consoles, Catheters, and Guidewires), Application (Coronary Angioplasty, Stent Placement, and Thrombectomy), End User (Hospitals, Cath Labs, and Others) - Industry Trends and Forecast to 2032
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Size
- The global robot assisted percutaneous coronary intervention (PCI) market size was valued at USD 18.33 billion in 2024 and is expected to reach USD 224.84 billion by 2032, at a CAGR of 36.80% during the forecast period
- This growth is driven by factors such as the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and advancements in robotic-assisted surgical technologies
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Analysis
- Robot assisted percutaneous coronary intervention (PCI) systems are advanced medical technologies that enhance precision and control during coronary procedures by enabling interventional cardiologists to perform surgeries with robotic assistance
- The growth of this market is significantly driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive interventions, and continuous technological advancements in robotic-assisted platforms
- North America is expected to dominate the robot assisted percutaneous coronary intervention (PCI) market with a market share of 40.4%, due to robust healthcare infrastructure, early adoption of advanced robotic technologies, and a high burden of cardiovascular diseases
- Asia-Pacific is expected to be the fastest growing region in the robot assisted percutaneous coronary intervention (PCI) market with a market share of 17.8%, due to the rising incidence of coronary artery disease, improving healthcare infrastructure, and growing demand for advanced surgical technologies
- Robot-assisted procedures segment is expected to dominate the market with a market share of 62.5% due to its superior precision, enhanced control during complex procedures, reduced risk of operator fatigue, and lower radiation exposure
Report Scope and Robot Assisted Percutaneous Coronary Intervention (PCI) Market Segmentation
|
Attributes |
Robot Assisted Percutaneous Coronary Intervention (PCI) Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Trends
“Integration of Robotics, AI, and Remote Navigation in Interventional Cardiology”
- One key trend in the robot assisted PCI market is the integration of robotics with artificial intelligence (AI) and remote navigation technologies to enhance procedural precision and safety
- These innovations allow for improved control over catheter movement, reduced radiation exposure for clinicians, and increased procedural efficiency through automated or semi-automated navigation
- For instance, robotic PCI platforms now feature AI-driven decision support tools and remote operation capabilities, enabling expert intervention even in remote or underserved areas, which is particularly valuable during emergencies or staffing shortages
- These advancements are reshaping interventional cardiology by enabling more consistent outcomes, expanding access to specialized procedures, and driving demand for intelligent robotic systems in catheter-based cardiovascular interventions
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Dynamics
Driver
“Rising Cardiovascular Disease Burden and Demand for Precision Treatment”
- The increasing prevalence of cardiovascular diseases, including coronary artery disease (CAD), is a major factor driving the demand for robot assisted PCI systems
- As sedentary lifestyles, unhealthy diets, and aging populations contribute to a global rise in heart-related conditions, there is a growing need for advanced, precise, and minimally invasive treatment options
- Robot assisted PCI offers enhanced precision, stability, and control during procedures, leading to reduced procedural errors, lower radiation exposure, and improved patient outcomes
For instance,
- According to the World Health Organization (WHO) in 2023, cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths each year. This growing burden necessitates advanced interventional solutions such as robotic PCI systems
- As the global cardiovascular disease burden continues to rise, the adoption of robotic PCI technologies is accelerating, driven by their ability to deliver safer and more effective interventions
Opportunity
“Enhancing Interventional Cardiology with AI and Remote Robotics”
- The integration of artificial intelligence (AI) and remote robotic capabilities in PCI systems presents a transformative opportunity to improve procedural precision, reduce operator fatigue, and expand access to care in underserved regions
- AI can assist interventional cardiologists by analyzing procedural data in real-time, offering decision support, predicting complications, and suggesting optimal stent placement or navigation pathways
- Remote robotic capabilities enable expert operators to perform PCI procedures across geographic barriers, improving access to specialized care in rural or low-resource settings
For instance,
- In September 2023, the Journal of the American College of Cardiology highlighted advancements in remote robotic PCI systems, noting successful trials where interventional cardiologists performed procedures over long distances using AI-assisted robotic platforms. These systems demonstrated high procedural success rates and significantly reduced radiation exposure to medical staff
- The convergence of AI and remote robotics in PCI opens new possibilities for global cardiac care, enabling high-precision interventions, reducing disparities in access, and optimizing patient outcomes through data-driven insights
Restraint/Challenge
“High Equipment Costs Hindering Market Penetration”
- The high cost of robotic-assisted PCI systems remains a significant challenge, particularly for healthcare facilities in developing regions with limited budgets
- These advanced robotic systems can cost several hundred thousand dollars, which poses a financial barrier for smaller hospitals and clinics looking to invest in such technology
- The cost of purchasing, maintaining, and upgrading these systems often outweighs the perceived benefits for institutions with limited resources, leading to a slower adoption rate in low- and middle-income countries
For instance,
- In March 2024, according to a report by the World Health Organization (WHO), the high cost of robotic surgical systems, including those used in PCI, was identified as one of the key factors limiting their widespread adoption in low-resource regions, thereby affecting the accessibility and quality of cardiovascular care in these areas
- As a result, the limited market penetration of robotic-assisted PCI systems in these regions is hindering the overall growth potential of the market
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Scope
The market is segmented on the basis of product type, component, application, and end user
|
Segmentation |
Sub-Segmentation |
|
By Product Type |
|
|
By Component |
|
|
By Application |
|
|
By End User |
|
In 2025, the robot-assisted procedures is projected to dominate the market with a largest share in product type segment
The robot-assisted procedures segment is expected to dominate the robot assisted percutaneous coronary intervention (PCI) market with the largest share of 62.5% in 2025 due to its superior precision, enhanced control during complex procedures, reduced risk of operator fatigue, and lower radiation exposure. These advantages contribute to improved clinical outcomes, greater procedural efficiency, and growing adoption across advanced cardiac care centers.
The robotic systems is expected to account for the largest share during the forecast period in component market
In 2025, the robotic systems segment is expected to dominate the market with the largest market share of 46.5% due to its pivotal role in enhancing surgical precision, minimizing human error, and reducing radiation exposure. These systems offer advanced control and real-time imaging integration, enabling more accurate stent placement and navigation. The growing preference for minimally invasive, technology-driven cardiac interventions is fueling their widespread adoption.
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Regional Analysis
“North America Holds the Largest Share in the Robot Assisted Percutaneous Coronary Intervention (PCI) Market”
- North America dominates the robot assisted percutaneous coronary intervention (PCI) market with a market share of estimated 40.4%, driven, by robust healthcare infrastructure, early adoption of advanced robotic technologies, and a high burden of cardiovascular diseases
- U.S. holds a market share of 55.5%, due to the growing demand for minimally invasive cardiac procedures, well-established reimbursement frameworks, and the presence of major robotic system manufacturers and healthcare providers
- Strong investments in research & development, along with favorable regulatory support for innovation in interventional cardiology, further boost market growth
- In addition, the increasing number of PCI procedures and growing awareness about the benefits of robotic systems in reducing radiation exposure and improving precision are accelerating adoption across the region
“Asia-Pacific is Projected to Register the Highest CAGR in the Robot Assisted Percutaneous Coronary Intervention (PCI) Market”
- Asia-Pacific is expected to witness the highest growth rate in the robot assisted percutaneous coronary intervention (PCI) market with a market share of 17.8%, driven by the rising incidence of coronary artery disease, improving healthcare infrastructure, and growing demand for advanced surgical technologies
- Countries such as China, India, and Japan are emerging as key markets due to their large patient populations, growing healthcare expenditure, and increasing availability of robotic PCI systems
- Japan continues to play a leading role in the adoption of robotic cardiovascular interventions, backed by strong technological innovation and high standards in cardiac care
- India is projected to register the highest CAGR in the robot assisted percutaneous coronary intervention (PCI) market, driven by a rapidly increasing burden of cardiovascular disease, expanding cardiac care facilities, and supportive government initiatives to modernize healthcare infrastructure
Robot Assisted Percutaneous Coronary Intervention (PCI) Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Siemens Healthineers AG (Germany)
- Robocath, Inc. (France)
- Stereotaxis, Inc. (U.S.)
- Medtronic (Ireland)
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- Terumo Corporation (Japan)
- BIOTRONIK SE & Co. KG (Germany)
- MicroPort Scientific Corporation (China)
- OrbusNeich Medical Group Holdings Limited (Hong Kong)
- Biosensors International Group, Ltd. (Singapore)
- Cordis (U.S.)
- B. Braun SE (Germany)
- ASAHI INTECC CO., LTD. (Japan)
- Meril Life Sciences Pvt. Ltd. (India)
- Hansen Medical, Inc. (U.S.)
- Catheter Precision, Inc. (U.S.)
- Intuitive Surgical (U.S.)
- Stryker (U.S.)
Latest Developments in Global Robot Assisted Percutaneous Coronary Intervention (PCI) Market
- In April 2025, researchers introduced Sim4EndoR, a reinforcement learning-based simulation platform designed to enhance task-level autonomy in endovascular robotics. This platform aims to improve precision and safety in robotic-assisted PCI by providing a risk-free environment for developing and refining autonomous systems, potentially reducing reliance on human operators and minimizing procedural variability
- In April 2025, researchers introduced Sim4EndoR, a reinforcement learning-based simulation platform designed to enhance task-level autonomy in endovascular robotics. This platform aims to improve precision and safety in robotic-assisted PCI by providing a risk-free environment for developing and refining autonomous systems, potentially reducing reliance on human operators and minimizing procedural variability
- In October 2024, a study published in the Journal of the Society for Cardiovascular Angiography & Interventions highlighted the benefits of robotic-assisted PCI in reducing occupational hazards for interventional cardiologists. The study emphasized that robotic systems can minimize radiation exposure and physical strain, contributing to safer working conditions for medical professionals
- In September 2024, the International Journal of Cardiovascular Research reported on the latest advancements in robotic PCI technology, focusing on developments in procedural complexity, tele-stenting, and training methods. These innovations are contributing to the global expansion of robotic-assisted PCI by enhancing procedural efficiency and accessibility
- In January 2024, the American College of Cardiology published an article discussing the increasing adoption of robotic-assisted solutions in cardiovascular interventions. The article noted that as market dynamics evolve and more surgeons become proficient with robotic systems, the prevalence of robotic-assisted PCI is expected to rise, supported by accumulating evidence of its benefits
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
